Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous …
Y Li, Z Liang, L Qin, M Wang, X Wang, H Zhang, Y Liu… - The Lancet, 2022 - thelancet.com
Background Previous randomised trials of bivalirudin versus heparin in patients with ST-
segment elevation myocardial infarction (STEMI) undergoing primary percutaneous …
segment elevation myocardial infarction (STEMI) undergoing primary percutaneous …
Cardiac Interventions in Patients With Active, Advanced Solid and Hematologic Malignancies: JACC: CardioOncology State-of-the-Art Review
Invasive cardiac interventions are recommended to treat ST-segment elevation myocardial
infarction, non–ST-segment elevation acute coronary syndromes, multivessel coronary …
infarction, non–ST-segment elevation acute coronary syndromes, multivessel coronary …
[HTML][HTML] Invasive cardiac interventions in patients with active, advanced solid and hematologic malignancies: a conceptual framework: JACC: CardioOncology state-of …
Invasive cardiac interventions are recommended to treat ST-segment elevation myocardial
infarction, non–ST-segment elevation acute coronary syndromes, multivessel coronary …
infarction, non–ST-segment elevation acute coronary syndromes, multivessel coronary …
Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial
D Giacoppo, HA Alvarez-Covarrubias… - European heart …, 2023 - academic.oup.com
Aims The best interventional strategy for the treatment of drug-eluting stent (DES) in-stent
restenosis (ISR) is still unclear and no data from randomized trials beyond 3-year follow-up …
restenosis (ISR) is still unclear and no data from randomized trials beyond 3-year follow-up …
Pulmonary artery catheter use and outcomes in patients with ST-elevation myocardial infarction and cardiogenic shock treated with Impella (a nationwide analysis …
The role of continuous hemodynamic assessment with pulmonary artery (PA) catheter
placement in cardiogenic shock (CS) remains debated. We aimed to assess the association …
placement in cardiogenic shock (CS) remains debated. We aimed to assess the association …
“Main vessel-oriented” treatment strategy versus “open side branch” treatment strategy in acute coronary syndrome patients with culprit bifurcation lesions
Percutaneous coronary intervention of bifurcation lesions is associated with an increased
risk of complications in patients with acute coronary syndrome (ACS). The study aimed to …
risk of complications in patients with acute coronary syndrome (ACS). The study aimed to …
[HTML][HTML] Prepercutaneous coronary intervention Zalunfiban dose-response relationship to target vessel blood flow at initial angiogram in st-elevation myocardial …
SAOF Rikken, WL Bor, A Selvarajah, KL Zheng… - American heart …, 2023 - Elsevier
Background Zalunfiban (RUC-4) is a novel, subcutaneously administered glycoprotein
IIb/IIIa inhibitor (GPI) designed for prehospital treatment to initiate reperfusion in the infarct …
IIb/IIIa inhibitor (GPI) designed for prehospital treatment to initiate reperfusion in the infarct …
Polypharmacy and bleeding outcomes after percutaneous coronary intervention
K Yamamoto, T Morimoto, M Natsuaki, H Shiomi… - Circulation …, 2024 - jstage.jst.go.jp
Background: Polypharmacy was reported to be associated with major bleeding in various
populations. However, there are no data on polypharmacy and its association with bleeding …
populations. However, there are no data on polypharmacy and its association with bleeding …
[HTML][HTML] Benchmarking system monitoring on quality improvement in percutaneous coronary intervention: a nationwide registry in Japan
Abstract Background Quality indicators (QIs) have been developed to improve and
standardize care quality in percutaneous coronary intervention (PCI). In Japan, consecutive …
standardize care quality in percutaneous coronary intervention (PCI). In Japan, consecutive …
Optimal hemostatic band duration after transradial angiography or intervention: insights from a mixed treatment comparison meta-analysis of randomized trials
MH Maqsood, S Pancholy, KA Tuozzo… - Circulation …, 2023 - Am Heart Assoc
Background: The optimal duration of hemostatic compression post transradial access is
controversial. Longer duration increases the risk of radial artery occlusion (RAO) while …
controversial. Longer duration increases the risk of radial artery occlusion (RAO) while …